Table 3.
Covariates by Cluster Membership
| Covariate | Asymptomatic Cluster (N=487) | Highly Symptomatic Cluster (N=142) | With Activity Cluster (N=326) | Mild Diffuse Cluster (N=336) |
|---|---|---|---|---|
| Gender | † | † | * | |
| Male | 377 (77.4%) | 71 (50%) | 178 (54.6%) | 235 (69.9%) |
| Female | 110 (22.6%) | 71 (50%) | 148 (45.4%) | 101 (30.1%) |
| Age | 58.6 (±12.4) | 59.8 (±10.5) | 59.1 (±12.2) | 56.9 (±11.6) * |
| AF Type | † | * | ||
| Paroxysmal | 265 (54.4%) | 46 (32.4%) | 181 (55.5%) | 168 (50%) |
| Persistent | 185 (38%) | 87 (61.3%) | 135 (41.4%) | 156 (46.4%) |
| Permanent | 37 (7.6%) | 9 (6.3%) | 10 (3.1%) | 12 (3.6%) |
| Ejection Fraction | 56.1 (±9) | 52.8 (±12.1) | 56.3 (±9.7) | 54.8 (±10) |
| Body Mass Index | 30 (±5.7) | 33.8 (±7.3) † | 32 (±6.9) * | 30 (±5.9) |
| Anti-arrhythmic | 251 (51.5%) | 91 (64.1%) | 225 (69%) * | 183 (54.5%) |
| Heart Failure | 45 (9.2%) | 48 (33.8%) * | 46 (14.1%) | 38 (11.3%) |
| Coronary Disease | 84 (17.3%) | 51 (35.9%) * | 92 (28.2%) † | 43 (12.8%) |
| Ablation | 202 (41.5%) | 89 (62.7%) † | 220 (67.5%) † | 202 (60.1%) † |
Values are expressed as N (%) or Mean (±SD);
*
p<0.05,
†
p<0.001.